Teva Pharmaceutical Industries Ltd. ADR (TEVA) Social Stream



Teva Pharmaceutical Industries Ltd. ADR (TEVA): $10.66

-0.05 (-0.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering TEVA PHARMACEUTICAL INDUSTRIES LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-30 10 $11 $10 $10.5 $10.54 -0.38%
2022-02-07 11 $11 $10 $10.5 $10.54 -0.38%
2022-02-10 11 $11 $9 $10.375 $10.54 -1.57%
2022-03-25 12 $11 $9 $10.444 $10.54 -0.91%
2022-04-05 13 $13 $9 $10.7 $10.54 1.52%
2022-04-28 12 $13 $10 $10.777 $10.54 2.25%
2022-05-04 12 $13 $10 $10.75 $10.54 1.99%
2022-05-16 11 $13 $7 $10.125 $10.54 -3.94%
2022-06-10 12 $13 $7 $10.125 $10.54 -3.94%
2022-06-14 11 $13 $7 $10.125 $10.54 -3.94%
2022-07-25 11 $13 $7 $10.25 $10.54 -2.75%
2022-07-28 11 $13 $8 $10.428 $10.54 -1.06%
2022-08-04 10 $13 $8 $10.375 $10.54 -1.57%
2022-09-17 10 $13 $8 $10.75 $10.54 1.99%
2022-10-14 9 $13 $8 $10.5 $10.54 -0.38%
2022-11-03 10 $13 $8 $10.5 $10.54 -0.38%
2022-11-04 12 $13 $8 $10.5 $10.54 -0.38%
2022-11-08 13 $13 $8 $10.444 $10.54 -0.91%
2022-11-14 13 $13 $8 $10.3 $10.54 -2.28%
2022-11-23 13 $13 $7 $10.2 $10.54 -3.23%
2022-12-16 13 $13 $7 $10.1 $10.54 -4.17%
2023-01-09 13 $13 $7 $10.3 $10.54 -2.28%
2023-01-26 13 $13 $7 $10.5 $10.54 -0.38%

The Trend in the Analyst Price Target


Over the past 131 days, TEVA's average price target has gone down $0.25.

Over the past 50 weeks, TEVA's average upside potential has been 15.71%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-10 12 13 7 10.125 8.32 21.69%
2022-08-05 10 13 8 10.750 10.69 0.56%
2022-08-24 10 13 8 10.750 10.03 7.18%
2022-11-08 13 13 8 10.444 9.08 15.02%
2022-12-16 13 13 7 10.100 8.69 16.23%

TEVA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 3 0 7 3 3 13

The Trend in the Broker Recommendations


TEVA's average broker recommendation rating worsened by 0.29 over the prior 28 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TEVA as an investment opportunity.

  • TEVA has a greater average analyst price target than 334.99% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, TEVA PHARMACEUTICAL INDUSTRIES LTD's upside potential (average analyst target price relative to current price) is higher than 434.19% of them.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD's number of analysts covering the stock is greater than 2429.77% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, TEVA PHARMACEUTICAL INDUSTRIES LTD's variance in analysts' estimates is lower than -794.54% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TEVA PHARMACEUTICAL INDUSTRIES LTD are PRGO, MRTX, and ZTS.

Make investment decisions regarding TEVA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 3.3129 seconds.